Osaka, Japan

Masaru Oogaki

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Astellas Pharma Gmbh, Wakunaga Pharmaceutical Co., Ltd.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masaru Oogaki. Retrieved from https://idiyas.com/inventor/masaru-oogaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masaru Oogaki: Innovator in Cephem Compounds

Introduction

Masaru Oogaki is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his work on cephem compounds. His innovative approach has led to the development of valuable compounds that have potential applications in medicine.

Latest Patents

Masaru Oogaki holds 1 patent related to cephem compounds. The present invention pertains to a compound of the formula [I], which showcases his expertise in chemical innovation and pharmaceutical development.

Career Highlights

Throughout his career, Oogaki has worked with prominent companies in the pharmaceutical industry. He has been associated with Astellas Pharma GmbH and Wakunaga Pharmaceutical Co., Ltd. His work in these organizations has allowed him to contribute to the advancement of medical science.

Collaborations

Masaru Oogaki has collaborated with esteemed colleagues, including Toshio Yamanaka and Kenji Murano. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Masaru Oogaki's contributions to the field of cephem compounds highlight his role as an influential inventor in the pharmaceutical industry. His work continues to inspire advancements in medical research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…